Unit
- Thalidomide tragedy: In the late 1950s, thalidomide was marketed as a sedative and antiemetic for pregnant women without adequate safety testing, leading to thousands of birth deformities worldwide. This catastrophe highlighted the need for rigorous pre-market evaluation and ethical oversight in clinical research.
- Nuremberg Code (1947): Developed after Nazi war crimes trials, this code established the principle of voluntary informed consent and the requirement that experiments yield fruitful results for the good of society. It remains a cornerstone of research ethics.
- Declaration of Helsinki (1964): Issued by the World Medical Association, this declaration added provisions for research combining medical care with experimental procedures, emphasizing that participant well-being must always override scientific or societal interests.
- Belmont Report (1979): This US document distilled ethical principles into respect for persons, beneficence, and justice. It introduced the requirement for Institutional Review Boards (IRBs) to protect human subjects in federally funded research.
- ICH GCP Guideline (1996): The International Council for Harmonisation created E6(R1) to unify trial standards across the EU, Japan, and the US. The guideline provides a single standard for designing, conducting, and reporting trials that is now adopted by regulators worldwide.
- E6(R2) revision (2016): This update modernized the guideline to address electronic records, risk-based monitoring, and sponsor oversight of outsourced activities. It reinforced the importance of quality management across the trial lifecycle.
- Global adoption: ICH GCP has been endorsed by the WHO and incorporated into national regulations in dozens of countries. It serves as a reference for ethics committees, regulatory agencies, and clinical research organizations globally.
- Ongoing evolution: The most recent updates under E6(R3) aim to integrate new trial designs such as decentralized and adaptive trials, reflecting the continuous refinement of standards to match technological and methodological advances.
- Key principles of ICH GCP: The guideline outlines 13 core principles that govern clinical trials, including the requirement that trials be scientifically sound, conducted per the protocol, and that the rights, safety, and well-being of participants are the most important consideration. It also mandates that adequate nonclinical and clinical data support the proposed trial before initiation.
- Role of Institutional Review Boards (IRBs): IRBs review protocols to ensure participant protection, including informed consent processes and risk-benefit analysis. They have authority to approve, modify, or disapprove studies. Independent ethics committees are a critical safeguard in the global clinical research ecosystem. IRBs must include diverse membership, with at least one non-scientific and one non-affiliated member.
- Informed consent process: ICH GCP requires that informed consent be documented by a dated signature of the participant or legally authorized representative, and that the consent form include specific elements such as purpose, procedures, risks, benefits, alternatives, and confidentiality. The participant must receive adequate time and opportunity to ask questions. The process must be free of coercion or undue influence, and participants must be informed they can withdraw at any time without penalty.
- Data integrity and source document verification: GCP emphasizes the accuracy, completeness, and verifiability of data. Source documents must be original records, and any corrections require an audit trail. Monitoring and auditing ensure that data reported in case report forms match source documents, preventing fabrication or errors. Essential documents must be maintained to allow reconstruction of the trial conduct and data generation.
Scope of Practice
Role: Clinical Research Coordinator vs. Investigator
Within scope:
- Coordinator: Schedule visits, collect informed consent under investigator supervision, maintain source documents, and assist with regulatory submissions.
- Investigator: Oversee all trial conduct at the site, ensure medical decisions align with protocol, and review adverse events.
Outside scope:
- Coordinator: Cannot modify the protocol, provide medical advice, or sign documents requiring physician attestation.
- Investigator: Should
Quick Revision
- Review the key concepts covered in Historical Evolution of Clinical Research Standards.
- Apply these principles in practical working contexts.
- Connect this material to the wider module objectives.